<![CDATA[Novo Nordisk A/S - Stock Exchange Announcements]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Status regarding Novo Nordisk's holding of its own shares (30 September 2008)]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Novo Nordisk provides update on corporate strategy at its Capital Markets Day]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Major shareholder notification]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[FDA schedules Advisory Committee meeting for liraglutide]]><![CDATA[Major shareholder notification]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Novo Nordisk A/S purchases B shares worth DKK 1.0 billion from Novo A/S as part of the ongoing share repurchase programme]]>
]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Financial statement for the period 1 January 2008 to 30 June 2008]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]>